Abstract:Background: Organoids, which enable disease modeling and drug screening closer to an in vivo environment, can be isolated and grown from organs such as the brain, small intestine, kidney, lungs, and liver. To facilitate the establishment of liver and small intestinal organoids, we developed efficient protocols for cholangiocytes and intestine crypts collecting and organoid culturing. Methods: Cholangiocytes were collected from intrahepatic bile ducts, the gallbladder, and small intestine crypts by gravity settling and multistep centrifugation methods. The cells isolated were embedded with Matrigel and grew in three-dimensional spheroids in a suitable culture medium. The stability of organoid cells was assessed by subculture, cryopreservation, and thawing. RNA and DNA extraction of organoids, as well as immunostaining procedure, were also optimized. Hand-picking procedures were developed and performed to ensure similar growth characteristics of organoids. Results: A large number of cholangiocytes and small intestine crypts were collected under these protocols. Cholangiocytes developed into cyst-like structures after 3–4 days in Matrigel. After 1–2 weeks of cultivation, small intestinal organoids (in-orgs) developed buds and formed a mature structure. Compared to organoids derived from the gallbladder, cholangiocyte organoids (Cho-orgs) from intrahepatic the bile ducts grew more slowly but had a longer culture term, expressed the cholangiocytes markers Krt19 and Krt7, and recapitulated in vivo tissue organization. Conclusions: Our protocols simplified the cell collection procedure and avoided the possibility of exposing tissue-derived stem cells to mechanical damage or chemical injury by gravity settling and multistep centrifugation. In addition, our approach allowed similar growth characteristics of organoids from different mammalian tissue sources. The protocol requires 2–4 weeks to establish a stable organoid growth system. Organoids could be stably passaged, cryopreserved, and recovered under protocol guidance. Besides, the organoids of cholangiocytes and small intestines retained their original tissue characteristics, such as tissue-specific marker expression, which prepares them for further experiments such as preclinical in vitro trials and mechanism research studies.

Isolation of mouse pancreatic islet Procr+ progenitors and long-term expansion of islet organoids in vitro

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Long-Term Expansion of Pancreatic Islet Organoids from Resident Procr+ Progenitors.

Simplified Protocol for Isolation of Multipotential NG2 Cells from Postnatal Mouse

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

In vitro pancreas organogenesis from dispersed mouse embryonic progenitors

Establishment of a High-Resolution 3D Modeling System for Studying Pancreatic Epithelial Cell Biology in Vitro

A Novel Efficient Technique of Pancreatic Islet Cell Isolation and Purification

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids

Isolation Of Pancreatic Progenitor Cells With The Surface Marker Of Hematopoietic Stem Cells

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Reformed islets: a long-term primary cell platform for exploring mouse and human islet biology

Three-in-one customized bioink for islet organoid: GelMA/ECM/PRP orchestrate pro-angiogenic and immunoregulatory function

Generation of human iPSC-derived pancreatic organoids to study pancreas development and disease

Scalable Generation of 3D Pancreatic Islet Organoids from Human Pluripotent Stem Cells in Suspension Bioreactors

A Novel Islet Isolation Method from Living Donors

Physiomimetic Fluidic Culture Platform on Microwell-Patterned Porous Collagen Scaffold for Human Pancreatic Islets

A Practical Guide to Rodent Islet Isolation and Assessment Revisited

Human amniotic mesenchymal stem cell-islet organoids enhance the efficiency of islet engraftment in a mouse diabetes model